Nurix Therapeutics, Inc.
Status: Publicly traded
Direct answer
Nurix Therapeutics, Inc. is publicly traded on NASDAQ under the ticker NRIX.
Nurix Therapeutics, Inc., a biopharmaceutical firm headquartered in San Francisco, California, was founded in 2009. This company, which rebranded from Nurix Inc. in October 2018, is dedicated to the identification, advancement, and commercialization of innovative small molecule treatments for various cancers and immune system disorders. Its robust pipeline features several key drug candidates: NX-2127 and NX-5948:...
Can you invest in Nurix Therapeutics, Inc.?
Yes. Nurix Therapeutics, Inc. trades publicly on NASDAQ as NRIX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Nurix Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.